So They Say

Superconductivity and acquired immune deficiency syndrome are remote from each other on the spectrum of research problems. But, like most other scientific matters of our time, they exist in a political dimension, since Washington controls money and policy for research. The different responses accorded these problems by the Reagan administration provide a tale of values—and it’s not a pleasant one. The political response to superconductivity was swift, sure-footed, and backed with

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Superconductivity and acquired immune deficiency syndrome are remote from each other on the spectrum of research problems. But, like most other scientific matters of our time, they exist in a political dimension, since Washington controls money and policy for research. The different responses accorded these problems by the Reagan administration provide a tale of values—and it’s not a pleasant one.

The political response to superconductivity was swift, sure-footed, and backed with money. It showed that government can move rapidly and sensibly—especially when Japan is pushing research in a hot field, huge problems remain to be solved, and the eventual market potential is in the billions.

In contrast, the Administration’s response to AIDS has been indifferent and pennypinching and a debacle in leadership....

How will history remember this President? Given his ignominious response to what could evolve into the greatest health crisis of modern times, Ronald Reagan could go into the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies